Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bicycle Therapeutics Plc (BCYC) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bicycle Therapeutics Plc. Table 2 shows the detailed insider transactions. This company's CIK number is 1761612.
Total stock buying since 2019: $66,996,314.
Total stock sales since 2019: $28,988,908.
Total stock option exercises since 2019: $6,031,759.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 41,524 | $446,872 | 0 | $0 |
| 2024 | 1,485,397 | $21,135,464 | 47,150 | $963,795 | 2,575 | $17,079 |
| 2023 | 0 | $0 | 26,728 | $707,564 | 0 | $0 |
| 2022 | 0 | $0 | 0 | $0 | 5,155 | $103,718 |
| 2021 | 0 | $0 | 670,108 | $26,057,927 | 548,369 | $5,856,364 |
| 2020 | 0 | $0 | 39,744 | $812,750 | 106,450 | $54,598 |
| 2019 | 3,275,775 | $45,860,850 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 10,599 | $77,059 | 0 | $0 |
| 2025-04 | 0 | $0 | 10,959 | $84,710 | 0 | $0 |
| 2025-01 | 0 | $0 | 19,966 | $285,103 | 0 | $0 |
| 2024-12 | 1,485,397 | $21,135,464 | 0 | $0 | 0 | $0 |
| 2024-11 | 0 | $0 | 6,256 | $156,306 | 2,575 | $17,079 |
| 2024-10 | 0 | $0 | 6,528 | $145,310 | 0 | $0 |
| 2024-07 | 0 | $0 | 7,268 | $142,739 | 0 | $0 |
| 2024-04 | 0 | $0 | 7,222 | $171,612 | 0 | $0 |
| 2024-01 | 0 | $0 | 19,876 | $347,828 | 0 | $0 |
| 2023-10 | 0 | $0 | 3,122 | $62,440 | 0 | $0 |
| 2023-07 | 0 | $0 | 3,248 | $81,523 | 0 | $0 |
| 2023-04 | 0 | $0 | 3,522 | $74,348 | 0 | $0 |
| 2023-01 | 0 | $0 | 16,836 | $489,253 | 0 | $0 |
| 2022-03 | 0 | $0 | 0 | $0 | 5,155 | $103,718 |
| 2021-12 | 0 | $0 | 150,000 | $8,653,889 | 165,477 | $1,486,363 |
| 2021-10 | 0 | $0 | 13,366 | $722,803 | 0 | $0 |
| 2021-09 | 0 | $0 | 57,040 | $2,233,995 | 38,890 | $529,960 |
| 2021-08 | 0 | $0 | 29,033 | $1,022,940 | 28,228 | $257,413 |
| 2021-07 | 0 | $0 | 230,218 | $7,690,822 | 165,674 | $2,026,543 |
| 2021-04 | 0 | $0 | 109,166 | $3,404,287 | 105,100 | $1,339,914 |
| 2021-03 | 0 | $0 | 40,000 | $1,177,239 | 20,000 | $176,321 |
| 2021-02 | 0 | $0 | 100 | $3,100 | 0 | $0 |
| 2021-01 | 0 | $0 | 41,185 | $1,148,852 | 25,000 | $39,850 |
| 2020-12 | 0 | $0 | 7,500 | $168,750 | 7,500 | $11,700 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-03 | Hannay Michael Charles Ferguson (CHIEF PROD & SUPPLY CHAIN OFF) | Sale | 248 | 7.44 | 1,845 |
| 2025-07-03 | Thompson Travis Alvin (CHIEF ACCOUNTING OFFICER) | Sale | 100 | 7.44 | 744 |
| 2025-07-03 | Milnes Alistair (CHIEF OPERATING OFFICER) | Sale | 966 | 7.44 | 7,187 |
| 2025-07-03 | Lee Kevin (CHIEF EXECUTIVE OFFICER) | Sale | 3,193 | 7.44 | 23,755 |
| 2025-07-03 | Skynner Michael (CHIEF TECHNOLOGY OFFICER) | Sale | 966 | 7.44 | 7,187 |
| 2025-07-02 | Hannay Michael Charles Ferguson (CHIEF PROD & SUPPLY CHAIN OFF) | Sale | 474 | 7.09 | 3,360 |
| 2025-07-02 | Thompson Travis Alvin (CHIEF ACCOUNTING OFFICER) | Sale | 206 | 7.09 | 1,460 |
| 2025-07-02 | Young Alethia (Chief Financial Officer) | Sale | 204 | 7.09 | 1,446 |
| 2025-07-02 | Milnes Alistair (CHIEF OPERATING OFFICER) | Sale | 1,149 | 7.09 | 8,146 |
| 2025-07-02 | Lee Kevin (CHIEF EXECUTIVE OFFICER) | Sale | 2,268 | 7.09 | 16,080 |
| 2025-07-02 | Skynner Michael (CHIEF TECHNOLOGY OFFICER) | Sale | 825 | 7.09 | 5,849 |
| 2025-04-03 | Hannay Michael Charles Ferguson (CHIEF PROD & SUPPLY CHAIN OFF) | Sale | 266 | 7.48 | 1,989 |
| 2025-04-03 | Thompson Travis Alvin (CHIEF ACCOUNTING OFFICER) | Sale | 109 | 7.48 | 815 |
| 2025-04-03 | Milnes Alistair (CHIEF OPERATING OFFICER) | Sale | 1,038 | 7.48 | 7,764 |
| 2025-04-03 | Lee Kevin (CHIEF EXECUTIVE OFFICER) | Sale | 3,432 | 7.48 | 25,671 |
| 2025-04-03 | Skynner Michael (CHIEF TECHNOLOGY OFFICER) | Sale | 1,038 | 7.48 | 7,764 |
| 2025-04-02 | Hannay Michael Charles Ferguson (CHIEF PROD & SUPPLY CHAIN OFF) | Sale | 467 | 8.02 | 3,745 |
| 2025-04-02 | Thompson Travis Alvin (CHIEF ACCOUNTING OFFICER) | Sale | 210 | 8.02 | 1,684 |
| 2025-04-02 | Young Alethia (Chief Financial Officer) | Sale | 215 | 8.02 | 1,724 |
| 2025-04-02 | Milnes Alistair (CHIEF OPERATING OFFICER) | Sale | 1,133 | 8.02 | 9,086 |
| 2025-04-02 | Lee Kevin (CHIEF EXECUTIVE OFFICER) | Sale | 2,237 | 8.02 | 17,940 |
| 2025-04-02 | Skynner Michael (CHIEF TECHNOLOGY OFFICER) | Sale | 814 | 8.02 | 6,528 |
| 2025-01-06 | Thompson Travis Alvin (CHIEF ACCOUNTING OFFICER) | Sale | 2,686 | 15.00 | 40,290 |
| 2025-01-03 | Thompson Travis Alvin (CHIEF ACCOUNTING OFFICER) | Sale | 159 | 14.75 | 2,345 |
| 2025-01-03 | Milnes Alistair (CHIEF OPERATING OFFICER) | Sale | 936 | 14.75 | 13,806 |
| 2025-01-03 | Crockett Nigel (CHIEF BUSINESS OFFICER) | Sale | 936 | 14.75 | 13,806 |
| 2025-01-02 | Thompson Travis Alvin (CHIEF ACCOUNTING OFFICER) | Sale | 1,750 | 14.09 | 24,657 |
| 2025-01-02 | Young Alethia (Chief Financial Officer) | Sale | 1,395 | 14.09 | 19,655 |
| 2025-01-02 | Milnes Alistair (CHIEF OPERATING OFFICER) | Sale | 4,578 | 14.09 | 64,504 |
| 2025-01-02 | Crockett Nigel (CHIEF BUSINESS OFFICER) | Sale | 2,583 | 14.09 | 36,394 |
| 2025-01-02 | Arroyo Santiago (CHIEF DEVELOPMENT OFFICER) | Sale | 4,943 | 14.09 | 69,646 |
| 2024-12-16 | Baker Julian | Buy | 500,000 | 15.34 | 7,671,000 |
| 2024-12-13 | Baker Julian | Buy | 985,397 | 13.66 | 13,464,464 |
| 2024-11-11 | Thompson Travis Alvin (CHIEF ACCOUNTING OFFICER) | Sale | 6,256 | 24.98 | 156,306 |
| 2024-11-11 | Thompson Travis Alvin (CHIEF ACCOUNTING OFFICER) | Option Ex | 2,575 | 6.63 | 17,079 |
| 2024-10-03 | Hannay Michael Charles Ferguson (CHIEF PROD & SUPPLY CHAIN OFF) | Sale | 247 | 22.26 | 5,498 |
| 2024-10-03 | Thompson Travis Alvin (CHIEF ACCOUNTING OFFICER) | Sale | 153 | 22.26 | 3,405 |
| 2024-10-03 | Milnes Alistair (CHIEF OPERATING OFFICER) | Sale | 972 | 22.26 | 21,636 |
| 2024-10-03 | Crockett Nigel (CHIEF BUSINESS OFFICER) | Sale | 972 | 22.26 | 21,636 |
| 2024-10-03 | Lee Kevin (CHIEF EXECUTIVE OFFICER) | Sale | 3,212 | 22.26 | 71,499 |
| 2024-10-03 | Skynner Michael (CHIEF TECHNOLOGY OFFICER) | Sale | 972 | 22.26 | 21,636 |
| 2024-07-03 | Hannay Michael Charles Ferguson (CHIEF PROD & SUPPLY CHAIN OFF) | Sale | 246 | 19.64 | 4,831 |
| 2024-07-03 | Thompson Travis Alvin (CHIEF ACCOUNTING OFFICER) | Sale | 148 | 19.64 | 2,906 |
| 2024-07-03 | Milnes Alistair (CHIEF OPERATING OFFICER) | Sale | 967 | 19.64 | 18,991 |
| 2024-07-03 | Crockett Nigel (CHIEF BUSINESS OFFICER) | Sale | 967 | 19.64 | 18,991 |
| 2024-07-03 | Lee Kevin (CHIEF EXECUTIVE OFFICER) | Sale | 3,194 | 19.64 | 62,730 |
| 2024-07-03 | Keen Nicholas (CHIEF SCIENTIFIC OFFICER) | Sale | 779 | 19.64 | 15,299 |
| 2024-07-03 | Skynner Michael (CHIEF TECHNOLOGY OFFICER) | Sale | 967 | 19.64 | 18,991 |
| 2024-04-11 | Hannay Michael Charles Ferguson (CHIEF PROD & SUPPLY CHAIN OFF) | Sale | 257 | 22.49 | 5,779 |
| 2024-04-03 | Thompson Travis Alvin (CHIEF ACCOUNTING OFFICER) | Sale | 152 | 23.81 | 3,619 |
| 2024-04-03 | Milnes Alistair (CHIEF OPERATING OFFICER) | Sale | 955 | 23.81 | 22,738 |
| 2024-04-03 | Crockett Nigel (CHIEF BUSINESS OFFICER) | Sale | 955 | 23.81 | 22,738 |
| 2024-04-03 | Lee Kevin (CHIEF EXECUTIVE OFFICER) | Sale | 3,158 | 23.81 | 75,191 |
| 2024-04-03 | Keen Nicholas (CHIEF SCIENTIFIC OFFICER) | Sale | 790 | 23.81 | 18,809 |
| 2024-04-03 | Skynner Michael (CHIEF TECHNOLOGY OFFICER) | Sale | 955 | 23.81 | 22,738 |
| 2024-01-03 | Thompson Travis Alvin (Chief Accounting Officer) | Sale | 604 | 17.50 | 10,570 |
| 2024-01-03 | Milnes Alistair (Chief Operating Officer) | Sale | 2,643 | 17.50 | 46,252 |
| 2024-01-03 | Crockett Nigel (Chief Business Officer) | Sale | 2,643 | 17.50 | 46,252 |
| 2024-01-03 | Lee Kevin (Chief Executive Officer) | Sale | 8,703 | 17.50 | 152,302 |
| 2024-01-03 | Keen Nicholas (Chief Scientific Officer) | Sale | 2,640 | 17.50 | 46,200 |
| 2024-01-03 | Skynner Michael (Chief Technology Officer) | Sale | 2,643 | 17.50 | 46,252 |
| 2023-10-03 | Thompson Travis Alvin (Chief Accounting Officer) | Sale | 54 | 20.00 | 1,080 |
| 2023-10-03 | Milnes Alistair (Chief Operating Officer) | Sale | 442 | 20.00 | 8,840 |
| 2023-10-03 | Crockett Nigel (Chief Business Officer) | Sale | 442 | 20.00 | 8,840 |
| 2023-10-03 | Lee Kevin (Chief Executive Officer) | Sale | 1,470 | 20.00 | 29,400 |
| 2023-10-03 | Keen Nicholas (Chief Scientific Officer) | Sale | 272 | 20.00 | 5,440 |
| 2023-10-03 | Skynner Michael (Chief Technology Officer) | Sale | 442 | 20.00 | 8,840 |
| 2023-07-03 | Thompson Travis Alvin (Chief Accounting Officer) | Sale | 61 | 25.10 | 1,531 |
| 2023-07-03 | Milnes Alistair (Chief Operating Officer) | Sale | 451 | 25.10 | 11,320 |
| 2023-07-03 | Crockett Nigel (Chief Business Officer) | Sale | 451 | 25.10 | 11,320 |
| 2023-07-03 | Lee Kevin (Chief Executive Officer) | Sale | 1,498 | 25.10 | 37,599 |
| 2023-07-03 | Keen Nicholas (Chief Scientific Officer) | Sale | 336 | 25.10 | 8,433 |
| 2023-07-03 | Skynner Michael (Chief Technology Officer) | Sale | 451 | 25.10 | 11,320 |
| 2023-04-03 | Milnes Alistair (Chief Operating Officer) | Sale | 447 | 21.11 | 9,436 |
| 2023-04-03 | Crockett Nigel (Chief Business Officer) | Sale | 447 | 21.11 | 9,436 |
| 2023-04-03 | Lee Kevin (Chief Executive Officer) | Sale | 1,486 | 21.11 | 31,369 |
| 2023-04-03 | Keen Nicholas (Chief Scientific Officer) | Sale | 319 | 21.11 | 6,734 |
| 2023-04-03 | Skynner Michael (Chief Technology Officer) | Sale | 447 | 21.11 | 9,436 |
| 2023-04-03 | Kalowski Lee (President and CFO) | Sale | 376 | 21.11 | 7,937 |
| 2023-01-03 | Milnes Alistair (Chief Operating Officer) | Sale | 1,801 | 29.06 | 52,337 |
| 2023-01-03 | Smethurst Dominic (Chief Medical Officer) | Sale | 1,801 | 29.06 | 52,337 |
| 2023-01-03 | Crockett Nigel (Chief Business Officer) | Sale | 1,801 | 29.06 | 52,337 |
| 2023-01-03 | Lee Kevin (Chief Executive Officer) | Sale | 6,000 | 29.06 | 174,360 |
| 2023-01-03 | Keen Nicholas (Chief Scientific Officer) | Sale | 1,817 | 29.06 | 52,802 |
| 2023-01-03 | Skynner Michael (Chief Technology Officer) | Sale | 1,801 | 29.06 | 52,337 |
| 2023-01-03 | Kalowski Lee (President and CFO) | Sale | 1,815 | 29.06 | 52,743 |
| 2022-03-25 | Milnes Alistair (Chief Operating Officer) | Option Ex | 5,155 | 20.12 | 103,718 |
| 2021-12-22 | Legault Pierre (Director) | Sale | 97,860 | 58.01 | 5,676,858 |
| 2021-12-22 | Legault Pierre (Director) | Option Ex | 97,860 | 8.48 | 829,852 |
| 2021-12-21 | Keen Nicholas (Chief Scientific Officer) | Option Ex | 15,477 | 14.00 | 216,678 |
| 2021-12-21 | Legault Pierre (Director) | Sale | 44,537 | 57.11 | 2,543,508 |
| 2021-12-21 | Legault Pierre (Director) | Option Ex | 44,537 | 8.44 | 375,892 |
| 2021-12-20 | Legault Pierre (Director) | Sale | 7,603 | 57.02 | 433,523 |
| 2021-12-20 | Legault Pierre (Director) | Option Ex | 7,603 | 8.41 | 63,941 |
| 2021-10-18 | Lee Kevin (Chief Executive Officer) | Sale | 49 | 60.00 | 2,940 |
| 2021-10-15 | Lee Kevin (Chief Executive Officer) | Sale | 320 | 60.05 | 19,216 |
| 2021-10-14 | Lee Kevin (Chief Executive Officer) | Sale | 4,631 | 60.00 | 277,860 |
| 2021-10-11 | Lee Kevin (Chief Executive Officer) | Sale | 5,000 | 54.22 | 271,100 |
| 2021-10-05 | Keen Nicholas (Chief Scientific Officer) | Sale | 2,178 | 45.10 | 98,227 |
| 2021-10-01 | Keen Nicholas (Chief Scientific Officer) | Sale | 1,188 | 45.00 | 53,460 |
| 2021-09-23 | Smethurst Dominic (Chief Medical Officer) | Option Ex | 6,000 | 18.55 | 111,300 |
| 2021-09-16 | Keen Nicholas (Chief Scientific Officer) | Sale | 1,955 | 45.01 | 87,994 |
| 2021-09-15 | Keen Nicholas (Chief Scientific Officer) | Sale | 3,000 | 45.00 | 135,000 |
| 2021-09-02 | Lee Kevin (Chief Executive Officer) | Sale | 5,000 | 40.00 | 200,000 |
| 2021-09-02 | Keen Nicholas (Chief Scientific Officer) | Sale | 10,000 | 40.00 | 400,000 |
| 2021-09-02 | Kalowski Lee (President and CFO) | Sale | 10,000 | 40.00 | 400,000 |
| 2021-09-02 | Kalowski Lee (President and CFO) | Option Ex | 10,000 | 9.82 | 98,200 |
| 2021-09-01 | Lee Kevin (Chief Executive Officer) | Sale | 27,085 | 37.33 | 1,011,001 |
| 2021-09-01 | Lee Kevin (Chief Executive Officer) | Option Ex | 22,890 | 14.00 | 320,460 |
| 2021-08-31 | Lee Kevin (Chief Executive Officer) | Sale | 11,225 | 36.66 | 411,452 |
| 2021-08-31 | Lee Kevin (Chief Executive Officer) | Option Ex | 10,420 | 14.00 | 145,880 |
| 2021-08-27 | Lee Kevin (Chief Executive Officer) | Sale | 1,808 | 36.02 | 65,124 |
| 2021-08-27 | Lee Kevin (Chief Executive Officer) | Option Ex | 1,808 | 14.00 | 25,312 |
| 2021-08-27 | Kalowski Lee (President and CFO) | Sale | 7,950 | 35.15 | 279,442 |
| 2021-08-27 | Kalowski Lee (President and CFO) | Option Ex | 7,950 | 8.73 | 69,403 |
| 2021-08-26 | Kalowski Lee (President and CFO) | Sale | 550 | 35.04 | 19,272 |
| 2021-08-26 | Kalowski Lee (President and CFO) | Option Ex | 550 | 8.76 | 4,818 |
| 2021-08-23 | Kalowski Lee (President and CFO) | Sale | 7,500 | 33.02 | 247,650 |
| 2021-08-23 | Kalowski Lee (President and CFO) | Option Ex | 7,500 | 1.60 | 12,000 |
| 2021-07-29 | Kalowski Lee (President and CFO) | Sale | 12,500 | 32.06 | 400,750 |
| 2021-07-29 | Kalowski Lee (President and CFO) | Option Ex | 12,500 | 1.63 | 20,375 |
| 2021-07-26 | Lee Kevin (Chief Executive Officer) | Sale | 100 | 36.00 | 3,600 |
| 2021-07-26 | Lee Kevin (Chief Executive Officer) | Option Ex | 100 | 14.00 | 1,400 |
| 2021-07-23 | Lee Kevin (Chief Executive Officer) | Sale | 4,782 | 36.02 | 172,247 |
| 2021-07-23 | Lee Kevin (Chief Executive Officer) | Option Ex | 4,782 | 14.00 | 66,948 |
| 2021-07-16 | Lee Kevin (Chief Executive Officer) | Sale | 609 | 34.00 | 20,706 |
| 2021-07-16 | Lee Kevin (Chief Executive Officer) | Option Ex | 609 | 14.00 | 8,526 |
| 2021-07-15 | Lee Kevin (Chief Executive Officer) | Sale | 21,970 | 34.28 | 753,131 |
| 2021-07-15 | Lee Kevin (Chief Executive Officer) | Option Ex | 21,970 | 14.00 | 307,580 |
| 2021-07-14 | Lee Kevin (Chief Executive Officer) | Sale | 14,465 | 34.21 | 494,804 |
| 2021-07-14 | Lee Kevin (Chief Executive Officer) | Option Ex | 8,331 | 14.00 | 116,634 |
| 2021-07-14 | Keen Nicholas (Chief Scientific Officer) | Sale | 10,000 | 35.00 | 350,000 |
| 2021-07-14 | Bingham Kate (Director) | Sale | 44,295 | 34.01 | 1,506,384 |
| 2021-07-13 | Crockett Nigel (Chief Business Officer) | Sale | 72,701 | 32.75 | 2,380,957 |
| 2021-07-13 | Crockett Nigel (Chief Business Officer) | Option Ex | 72,701 | 12.28 | 892,768 |
| 2021-07-13 | Lee Kevin (Chief Executive Officer) | Sale | 38,961 | 33.17 | 1,292,336 |
| 2021-07-13 | Lee Kevin (Chief Executive Officer) | Option Ex | 35,446 | 14.00 | 496,244 |
| 2021-07-13 | Bingham Kate (Director) | Sale | 600 | 33.50 | 20,100 |
| 2021-07-12 | Crockett Nigel (Chief Business Officer) | Sale | 7,028 | 32.03 | 225,106 |
| 2021-07-12 | Crockett Nigel (Chief Business Officer) | Option Ex | 7,028 | 12.28 | 86,303 |
| 2021-07-12 | Lee Kevin (Chief Executive Officer) | Sale | 1,936 | 32.04 | 62,029 |
| 2021-07-12 | Lee Kevin (Chief Executive Officer) | Option Ex | 1,936 | 14.00 | 27,104 |
| 2021-07-06 | Crockett Nigel (Chief Business Officer) | Sale | 271 | 32.00 | 8,672 |
| 2021-07-06 | Crockett Nigel (Chief Business Officer) | Option Ex | 271 | 9.82 | 2,661 |
| 2021-04-30 | Lee Kevin (Chief Executive Officer) | Sale | 30,406 | 30.39 | 923,886 |
| 2021-04-30 | Lee Kevin (Chief Executive Officer) | Option Ex | 30,406 | 14.00 | 425,684 |
| 2021-04-29 | Lee Kevin (Chief Executive Officer) | Sale | 6,018 | 30.65 | 184,451 |
| 2021-04-29 | Lee Kevin (Chief Executive Officer) | Option Ex | 6,018 | 14.00 | 84,252 |
| 2021-04-28 | Lee Kevin (Chief Executive Officer) | Sale | 22,495 | 31.82 | 715,903 |
| 2021-04-28 | Lee Kevin (Chief Executive Officer) | Option Ex | 22,495 | 14.00 | 314,930 |
| 2021-04-27 | Lee Kevin (Chief Executive Officer) | Sale | 6,636 | 31.04 | 205,948 |
| 2021-04-27 | Lee Kevin (Chief Executive Officer) | Option Ex | 6,636 | 14.00 | 92,904 |
| 2021-04-26 | Lee Kevin (Chief Executive Officer) | Sale | 18,611 | 31.07 | 578,150 |
| 2021-04-26 | Lee Kevin (Chief Executive Officer) | Option Ex | 14,545 | 14.00 | 203,630 |
| 2021-04-08 | Legault Pierre (Director) | Sale | 24,838 | 31.84 | 790,916 |
| 2021-04-08 | Legault Pierre (Director) | Option Ex | 24,838 | 8.74 | 217,084 |
| 2021-04-05 | Legault Pierre (Director) | Sale | 162 | 31.07 | 5,033 |
| 2021-04-05 | Legault Pierre (Director) | Option Ex | 162 | 8.83 | 1,430 |
| 2021-03-31 | Keen Nicholas (Chief Scientific Officer) | Sale | 10,000 | 30.00 | 300,000 |
| 2021-03-31 | Legault Pierre (Director) | Sale | 10,000 | 30.00 | 300,000 |
| 2021-03-31 | Legault Pierre (Director) | Option Ex | 10,000 | 8.78 | 87,800 |
| 2021-03-17 | Legault Pierre (Director) | Sale | 7,784 | 29.00 | 225,736 |
| 2021-03-17 | Legault Pierre (Director) | Option Ex | 7,784 | 8.85 | 68,888 |
| 2021-03-15 | Keen Nicholas (Chief Scientific Officer) | Sale | 217 | 28.00 | 6,076 |
| 2021-03-12 | Keen Nicholas (Chief Scientific Officer) | Sale | 9,783 | 28.74 | 281,163 |
| 2021-03-12 | Legault Pierre (Director) | Sale | 2,216 | 29.00 | 64,264 |
| 2021-03-12 | Legault Pierre (Director) | Option Ex | 2,216 | 8.86 | 19,633 |
| 2021-02-05 | Lee Kevin (Chief Executive Officer) | Sale | 100 | 31.00 | 3,100 |
| 2021-01-20 | Lee Kevin (Chief Executive Officer) | Sale | 1,185 | 32.12 | 38,057 |
| 2021-01-19 | Lee Kevin (Chief Executive Officer) | Sale | 5,000 | 30.15 | 150,745 |
| 2021-01-19 | Kalowski Lee (President and CFO) | Sale | 15,000 | 30.00 | 450,000 |
| 2021-01-19 | Kalowski Lee (President and CFO) | Option Ex | 15,000 | 1.59 | 23,850 |
| 2021-01-15 | Lee Kevin (Chief Executive Officer) | Sale | 5,000 | 27.01 | 135,050 |
| 2021-01-14 | Lee Kevin (Chief Executive Officer) | Sale | 5,000 | 25.00 | 125,000 |
| 2021-01-14 | Kalowski Lee (President and CFO) | Sale | 10,000 | 25.00 | 250,000 |
| 2021-01-14 | Kalowski Lee (President and CFO) | Option Ex | 10,000 | 1.60 | 16,000 |
| 2020-12-01 | Kalowski Lee (President and CFO) | Sale | 7,500 | 22.50 | 168,750 |
| 2020-12-01 | Kalowski Lee (President and CFO) | Option Ex | 7,500 | 1.56 | 11,700 |
| 2020-11-27 | Kalowski Lee (President and CFO) | Sale | 530 | 20.00 | 10,600 |
| 2020-11-27 | Kalowski Lee (President and CFO) | Option Ex | 530 | 1.56 | 826 |
| 2020-11-25 | Kalowski Lee (President and CFO) | Sale | 9,781 | 20.07 | 196,304 |
| 2020-11-25 | Kalowski Lee (President and CFO) | Option Ex | 9,781 | 1.56 | 15,258 |
| 2020-11-23 | Kalowski Lee (President and CFO) | Sale | 17,189 | 20.10 | 345,498 |
| 2020-11-23 | Kalowski Lee (President and CFO) | Option Ex | 17,189 | 1.56 | 26,814 |
| 2020-07-15 | Glaxosmithkline Plc | Sale | 3,147 | 19.33 | 60,818 |
| 2020-07-14 | Glaxosmithkline Plc | Sale | 1,597 | 19.27 | 30,780 |
| 2020-04-14 | Winter Gregory Paul (Director) | Option Ex | 71,450 | .00 | 0 |
| 2019-05-29 | Cambridge Innovation Capital (jersey) Ltd (10% Owner) | Buy | 314,286 | 14.00 | 4,400,004 |
| 2019-05-28 | Aquila Investments Iv | Buy | 364,286 | 14.00 | 5,100,004 |
| 2019-05-28 | Harland Deborah (Director) | Buy | 385,714 | 14.00 | 5,399,996 |
| 2019-05-28 | Anstey Michael (Director) | Buy | 314,286 | 14.00 | 4,400,004 |
| 2019-05-28 | Sv Life Sciences Fund V Strategic Partners, L.p. (10% Owner) | Buy | 385,715 | 14.00 | 5,400,010 |
| 2019-05-28 | Bingham Kate (Director) | Buy | 385,715 | 14.00 | 5,400,010 |
| 2019-05-28 | Glaxosmithkline Plc | Buy | 385,714 | 14.00 | 5,399,996 |
| 2019-05-28 | Novartis Ag (10% Owner) | Buy | 168,630 | 14.00 | 2,360,820 |
| 2019-05-27 | Ng Carolyn (Director) | Buy | 571,429 | 14.00 | 8,000,006 |
Insider trading activities including stock purchases, stock sales, and option exercises of BCYC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bicycle Therapeutics Plc (symbol BCYC, CIK number 1761612) see the Securities and Exchange Commission (SEC) website.